BGM Group Ltd.: updates and filings

BGMNASDAQHealthcare · Pharmaceutical Preparations

Price

$8.00

November 19, 2026

What Ploutos Investor adds for BGM

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 8 fiscal years, from FY2018
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The share price was recently adjusted for a split or a spin-off that the company's last filing does not include yet. Market value, P/E, yields and the other figures measured against the price would mix the new shares with the old figures, so we leave them out until the next filing.
  • The latest annual figures the company filed are for 2025, more than a year ago. Newer ones may be late.

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Jul 21, 2026 latest annual
  • Sep 24, 2026Current report (foreign company)
    Form6-K
  • Sep 8, 2026Current report (foreign company)
    Form6-K
  • Aug 28, 2026Current report (foreign company)
    Form6-K
  • Aug 11, 2026Current report (foreign company)
    Form6-K
  • Jul 30, 2026Current report (foreign company)
    Form6-K
  • Jul 28, 2026Current report (foreign company)
    Form6-K
  • Jul 21, 2026Annual report (foreign company)for the period to Sep 30, 2025
    Form20-F
  • Jul 13, 2026Current report (foreign company)
    Form6-K
  • Jun 17, 2026Current report (foreign company)
    Form6-K
  • Jun 9, 2026Current report (foreign company)
    Form6-K
  • May 18, 2026Current report (foreign company)
    Form6-K
  • May 7, 2026Current report (foreign company)
    Form6-K
  • Apr 30, 2026Current report (foreign company)
    Form6-K
  • Jan 30, 2026Notice that the annual report will be filed late
    FormNT 20-F
  • Jan 29, 2026Current report (foreign company)
    Form6-K
  • Dec 22, 2025Current report (foreign company)
    Form6-K
  • Aug 14, 2025Current report (foreign company)
    Form6-K
  • Jul 24, 2025Current report (foreign company)
    Form6-K
  • Jun 26, 2025Current report (foreign company)
    Form6-K
  • Jun 3, 2025Shares registered for employees
    FormS-8
  • May 28, 2025Current report (foreign company)
    Form6-K
  • May 28, 2025Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • May 28, 2025Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • May 27, 2025Over-5% holder statement (active) (amendment)
    FormSCHEDULE 13D/A
  • May 27, 2025Over-5% holder statement (active)
    FormSCHEDULE 13D

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Jun 17, 2019.

The full analysis

What do BGM's filings show?

The filings are where every one of BGM's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.